<DOC>
	<DOCNO>NCT01204190</DOCNO>
	<brief_summary>The primary objective trial examine whether ovulation suppress use hormone patch contain different dosage ethinyl estradiol ( EE ) gestodene ( GSD ) 3 treatment cycle . To end , blood level endogenous hormone ( hormone produce body ) measure transvaginal ultrasound examination conduct regular interval . In addition , concentration administer hormone EE GSD blood determine regular interval . With regard tolerability hormone patch subject ask regularly feel blood pressure , pulse body weight determine . In addition , blood urine safety examination conduct defined timepoints .</brief_summary>
	<brief_title>Investigation Three Contraceptive Hormone Patches Regard Inhibition Ovulation Following Application Over 3 Treatment Cycles Healthy , Young Women .</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<criteria>Healthy female volunteer age 18 35 year ( smoker old 30 year , inclusive ) ovulatory pretreatment cycle Contraindications use combine ( estrogen/gestodene ) contraceptive ( e.g . history venous arterial thromboembolic disease ) Regular intake medication Oral Contraception Clinically relevant finding ( blood pressure , physical gynecological examination , laboratory examination )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Administration</keyword>
	<keyword>Cutaneous</keyword>
</DOC>